Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19
U.S. Health Officials Urge Indoor Masking in Major Cities as ‘Tripledemic’ Rages
During the past few weeks, COVID-19, the flu, and respiratory syncytial virus have made millions of Americans ill
Preprint, Peer-Reviewed Pairs of Studies Generally Concordant
Sample sizes, primary end points, interpretations mainly concordant for studies published on medRxiv, then in journals
Viral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy
Viral rebound uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality
Recommendations Updated for Treatment, Prevention of HIV
Because people with HIV are living longer, management of comorbidities throughout the life span is increasingly important
Half of U.S. Adults Not Concerned About the Flu
American Heart Association advises flu vaccine is effective for prevention, particularly for seniors and those with heart disease
Paxlovid Safe for Pregnant Patients With COVID-19
However, unexpectedly high rate of cesarean deliveries seen in this cohort
JYNNEOS Vaccination Provides Protection Against Mpox
Mpox incidence was 9.6 times as high among unvaccinated persons than among those who had received two vaccine doses
Most Common Adverse Events With JYNNEOS Are Nonserious
Serious adverse events are rare in adults, and none have been identified among persons aged younger than 18 years
FDA Approves Bivalent COVID-19 Boosters for Children 6 Months and Older
Updated boosters protect against both the original strain of COVID-19 and highly contagious omicron variants
